Literature DB >> 23249995

Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.

Chun Cheng Andy Chen1, Aron M Geurts, Howard J Jacob, Fan Fan, Richard J Roman.   

Abstract

The present study employed a zinc-finger nuclease strategy to create heterozygous knockout (KO) rats for the transforming growth factor-β1 (Tgfb1) gene on the Dahl SS/Jr genetic background (TGF-β1(+/-) Dahl S). Intercrossing TGF-β1(+/-) rats did not produce any homozygous KO rats (66.4% +/-, 33.6% +/+), indicating that the mutation is embryonic lethal. Six-week-old wild-type (WT) littermates and TGF-β1(+/-) Dahl S rats were fed a 0.4% (low salt, LS) or 8% NaCl (high salt, HS) diet for 5 wk. Renal cortical expression of TGF-β1, urinary TGF-β1 excretion, proteinuria, glomerular injury and tubulointerstitial fibrosis, and systolic blood pressure were similar in WT and TGF-β1(+/-) Dahl S rats maintained on the LS diet. The expression and urinary excretion of TGF-β1 increased to a greater extent in WT than in TGF-β1(+/-)Dahl S rats fed an HS diet for 1 wk. Systolic blood pressure rose by the same extent to 235 ± 2 mmHg in WT and 239 ± 4 mmHg in TGF-β1(+/-) Dahl S rats fed a HS diet for 5 wk. However, urinary protein excretion was significantly lower in TGF-β1(+/-) Dahl S than in the WT animals. The degree of glomerular injury and renal cortical and outer medullary fibrosis was markedly less in TGF-β1(+/-) than in WT rats. These findings suggest that the loss of one copy of the TGF-β1 gene blunts the increase in renal TGF-β1 protein expression and slows the progression of proteinuria, glomerulosclerosis, and renal interstitial fibrosis in Dahl S rats fed an HS diet independently of changes in blood pressure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23249995      PMCID: PMC3568879          DOI: 10.1152/physiolgenomics.00119.2012

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  37 in total

1.  Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.

Authors:  Sydney R Murphy; Annette J Dahly-Vernon; Kathryn M J Dunn; Chun Cheng Andy Chen; Steven R Ledbetter; Jan M Williams; Richard J Roman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-04-25       Impact factor: 3.619

2.  TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.

Authors:  Dona T Wu; Markus Bitzer; Wenjun Ju; Peter Mundel; Erwin P Böttinger
Journal:  J Am Soc Nephrol       Date:  2005-10-05       Impact factor: 10.121

3.  Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

Authors:  Jan M Williams; Jin Zhang; Paula North; Steven Lacy; Michael Yakes; Annette Dahly-Vernon; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 4.  From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

Authors:  Gunter Wolf; Sheldon Chen; Fuad N Ziyadeh
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

5.  Generation of gene-specific mutated rats using zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Séverine Rémy; Xiaoxia Cui; Laurent Tesson; Claire Usal; Séverine Ménoret; Howard J Jacob; Ignacio Anegon; Roland Buelow
Journal:  Methods Mol Biol       Date:  2010

6.  Mechanism of dietary salt-mediated increase in intravascular production of TGF-beta1.

Authors:  Wei-Zhong Ying; Kristal Aaron; Paul W Sanders
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

7.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

Authors:  Yingjian Li; Young Sun Kang; Chunsun Dai; Lawrence P Kiss; Xiaoyan Wen; Youhua Liu
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

8.  Knockout rats via embryo microinjection of zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Yevgeniy Freyvert; Bryan Zeitler; Jeffrey C Miller; Vivian M Choi; Shirin S Jenkins; Adam Wood; Xiaoxia Cui; Xiangdong Meng; Anna Vincent; Stephen Lam; Mieczyslaw Michalkiewicz; Rebecca Schilling; Jamie Foeckler; Shawn Kalloway; Hartmut Weiler; Séverine Ménoret; Ignacio Anegon; Gregory D Davis; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Howard J Jacob; Roland Buelow
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

Review 9.  Vascular consequences of dietary salt intake.

Authors:  Paul W Sanders
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

Review 10.  Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.

Authors:  Hyun Soon Lee
Journal:  Cell Tissue Res       Date:  2011-05-04       Impact factor: 5.249

View more
  13 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Rats are the smart choice: Rationale for a renewed focus on rats in behavioral genetics.

Authors:  Clarissa C Parker; Hao Chen; Shelly B Flagel; Aron M Geurts; Jerry B Richards; Terry E Robinson; Leah C Solberg Woods; Abraham A Palmer
Journal:  Neuropharmacology       Date:  2013-06-18       Impact factor: 5.250

Review 3.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

4.  Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.

Authors:  Steven T Haller; Sivarajan Kumarasamy; David A Folt; Leah M Wuescher; Stanislaw Stepkowski; Manish Karamchandani; Harshal Waghulde; Blair Mell; Muhammad Chaudhry; Kyle Maxwell; Siddhi Upadhyaya; Christopher A Drummond; Jiang Tian; Wanda E Filipiak; Thomas L Saunders; Joseph I Shapiro; Bina Joe; Christopher J Cooper
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

Review 5.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

6.  Evidence of the Importance of Nox4 in Production of Hypertension in Dahl Salt-Sensitive Rats.

Authors:  Allen W Cowley; Chun Yang; Nadezhda N Zheleznova; Alexander Staruschenko; Theresa Kurth; Lisa Rein; Vikash Kumar; Katherine Sadovnikov; Alex Dayton; Matthew Hoffman; Robert P Ryan; Meredith M Skelton; Fahimeh Salehpour; Mahsa Ranji; Aron Geurts
Journal:  Hypertension       Date:  2015-12-07       Impact factor: 10.190

Review 7.  Precision gene editing technology and applications in nephrology.

Authors:  Zachary WareJoncas; Jarryd M Campbell; Gabriel Martínez-Gálvez; William A C Gendron; Michael A Barry; Peter C Harris; Caroline R Sussman; Stephen C Ekker
Journal:  Nat Rev Nephrol       Date:  2018-11       Impact factor: 28.314

8.  α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.

Authors:  Lydia Hering; Masudur Rahman; Henning Hoch; Lajos Markó; Guang Yang; Annika Reil; Mina Yakoub; Vikram Gupta; Sebastian A Potthoff; Oliver Vonend; Donna L Ralph; Susan B Gurley; Alicia A McDonough; Lars C Rump; Johannes Stegbauer
Journal:  J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 10.121

9.  Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.

Authors:  Takashi Hirata; Stanley V Smith; Teisuke Takahashi; Noriyuki Miyata; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2020-12-04       Impact factor: 4.030

10.  Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat.

Authors:  Zhen Jia; Ashley C Johnson; Xuexiang Wang; Zibiao Guo; Albert W Dreisbach; Jack R Lewin; Patrick B Kyle; Michael R Garrett
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.